Evaluation of Microbial Risk Factors in Relation to Clinical Effectiveness of Off-Label Bevacizumab Use for Retinal Disease Treatment: Research Article. Pak Euro. J. Med & LS. 2026;9(1):25-34. doi:10.31580/pjmls.v9i1.3417